NEXIEN BIOPHARMA, INC. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Glendale, CO
SEC filing record 1 source field available
Fiscal year end
30 June
NEXIEN BIOPHARMA, INC. has filed 201 SEC EDGAR filings since 14 Nov 2014

SEC filing history

Showing 1-10 of 10 matching filings.

Per page
25
Current page
1
10-K File 000-55320

10-K filing

Filing date
22 Oct 2024
Reporting date
30 Jun 2024
Next action
Verify source filing
10-K File 000-55320

10-K filing

Filing date
28 Sep 2023
Reporting date
30 Jun 2023
Next action
Verify source filing
10-K File 000-55320

10-K filing

Filing date
28 Sep 2022
Reporting date
30 Jun 2022
Next action
Verify source filing
10-K File 000-55320

10-K filing

Filing date
12 Oct 2021
Reporting date
30 Jun 2021
Next action
Verify source filing
10-K File 000-55320

10-K filing

Filing date
28 Sep 2020
Reporting date
30 Jun 2020
Next action
Verify source filing
10-K File 000-55320

10-K filing

Filing date
30 Sep 2019
Reporting date
30 Jun 2019
Next action
Verify source filing
10-K File 000-55320

10-K filing

Filing date
28 Sep 2018
Reporting date
30 Jun 2018
Next action
Verify source filing
10-K File 000-55320

ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED JUNE 30, 2017

Filing date
31 Jul 2017
Reporting date
30 Jun 2017
Next action
Verify source filing
10-K File 000-55320

FORM 10-K FOR THE YEAR ENDED JUNE 30, 2016

Filing date
28 Sep 2016
Reporting date
30 Jun 2016
Next action
Verify source filing
10-K File 000-55320

ANNUAL REPORT FOR THE YEAR ENDED JUNE 30, 2015

Filing date
15 Sep 2015
Reporting date
30 Jun 2015
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .